Literature DB >> 28891866

Passive transfer autoimmunity in a mouse model of complex regional pain syndrome.

Tian-Zhi Guo1, Xiaoyou Shi1,2,3, Wen-Wu Li1,2,3, Tzuping Wei1, John David Clark2,3, Wade S Kingery1.   

Abstract

It has been proposed that complex regional pain syndrome (CRPS) is a posttraumatic autoimmune disease, and we previously observed that B cells are required for the full expression of CRPS-like changes in a mouse tibia fracture CRPS model. The current study used the mouse model to evaluate the progression of postfracture CRPS-like changes in wild-type (WT) and muMT fracture mice lacking B cells and antibodies. The pronociceptive effects of injecting WT fracture mouse serum antibodies into muMT fracture mice were also evaluated. Postfracture pain behaviors transitioned from being initially dependent on both innate and autoimmune inflammatory mechanisms at 3 weeks after fracture to being entirely mediated by antibody responses at 12 weeks after fracture and spontaneously resolving by 21 weeks after fracture. Furthermore, serum IgM antibodies from WT fracture mice had pronociceptive effects in the fracture limb when injected into muMT fracture mice. IgM antibody levels gradually increased in the fracture limb hind paw skin, sciatic nerve, and corresponding lumbar cord, peaking at 12 to 18 weeks after fracture and then declining. Immunohistochemistry localized postfracture IgM antibody binding to antigens in the fracture limb hind paw dermal cell nuclei. We postulate that fracture induces expression of neoantigens in the fracture limb skin, sciatic nerve, and cord, which trigger B cells to secret IgM antibodies that bind those antigens and initiate a pronociceptive antibody response. Autoimmunity plays a key role in the progression of nociceptive and vascular changes in the mouse fracture model and potentially contributes to the CRPS disease process.

Entities:  

Mesh:

Year:  2017        PMID: 28891866      PMCID: PMC5680122          DOI: 10.1097/j.pain.0000000000001046

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   7.926


  57 in total

1.  Intravenous immunoglobulin response and evidence for pathogenic antibodies in a case of complex regional pain syndrome 1.

Authors:  Andreas Goebel; Michael Stock; Rob Deacon; Guenter Sprotte; Angela Vincent
Journal:  Ann Neurol       Date:  2005-03       Impact factor: 10.422

2.  B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies.

Authors:  Daniel A Winer; Shawn Winer; Lei Shen; Persis P Wadia; Jason Yantha; Geoffrey Paltser; Hubert Tsui; Ping Wu; Matthew G Davidson; Michael N Alonso; Hwei X Leong; Alec Glassford; Maria Caimol; Justin A Kenkel; Thomas F Tedder; Tracey McLaughlin; David B Miklos; H-Michael Dosch; Edgar G Engleman
Journal:  Nat Med       Date:  2011-04-17       Impact factor: 53.440

3.  Keratinocytes express cytokines and nerve growth factor in response to neuropeptide activation of the ERK1/2 and JNK MAPK transcription pathways.

Authors:  Xiaoyou Shi; Liping Wang; J David Clark; Wade S Kingery
Journal:  Regul Pept       Date:  2013-08-17

4.  Substance P signaling controls mast cell activation, degranulation, and nociceptive sensitization in a rat fracture model of complex regional pain syndrome.

Authors:  Wen-Wu Li; Tian-Zhi Guo; De-yong Liang; Yuan Sun; Wade S Kingery; J David Clark
Journal:  Anesthesiology       Date:  2012-04       Impact factor: 7.892

5.  Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients.

Authors:  P H Veldman; H M Reynen; I E Arntz; R J Goris
Journal:  Lancet       Date:  1993-10-23       Impact factor: 79.321

6.  Epidermal adrenergic signaling contributes to inflammation and pain sensitization in a rat model of complex regional pain syndrome.

Authors:  Wenwu Li; Xiaoyou Shi; Liping Wang; Tianzhi Guo; Tzuping Wei; Kejun Cheng; Kenner C Rice; Wade S Kingery; J David Clark
Journal:  Pain       Date:  2013-04-12       Impact factor: 6.961

7.  Reflex sympathetic dystrophy syndrome of the upper extremity: analysis of total outcome of management of 125 cases.

Authors:  J Subbarao; G K Stillwell
Journal:  Arch Phys Med Rehabil       Date:  1981-11       Impact factor: 3.966

8.  Mast cells are involved in inflammatory reactions during Complex Regional Pain Syndrome type 1.

Authors:  Frank J P M Huygen; Navin Ramdhani; Albert van Toorenenbergen; Jan Klein; Freek J Zijlstra
Journal:  Immunol Lett       Date:  2004-02-15       Impact factor: 3.685

9.  The analgesic potency of dexmedetomidine is enhanced after nerve injury: a possible role for peripheral alpha2-adrenoceptors.

Authors:  L R Poree; T Z Guo; W S Kingery; M Maze
Journal:  Anesth Analg       Date:  1998-10       Impact factor: 5.108

10.  Pentoxifylline attenuates nociceptive sensitization and cytokine expression in a tibia fracture rat model of complex regional pain syndrome.

Authors:  Tzuping Wei; Ilya Sabsovich; Tian-Zhi Guo; Xiaoyou Shi; Rong Zhao; Wenwu Li; Christian Geis; Claudia Sommer; Wade S Kingery; David J Clark
Journal:  Eur J Pain       Date:  2008-06-12       Impact factor: 3.931

View more
  17 in total

Review 1.  Complex Regional Pain Syndrome, Current Concepts and Treatment Options.

Authors:  Ivan Urits; Abra H Shen; Mark R Jones; Omar Viswanath; Alan D Kaye
Journal:  Curr Pain Headache Rep       Date:  2018-02-05

Review 2.  The Rodent Tibia Fracture Model: A Critical Review and Comparison With the Complex Regional Pain Syndrome Literature.

Authors:  Frank Birklein; Alaa Ibrahim; Tanja Schlereth; Wade S Kingery
Journal:  J Pain       Date:  2018-04-21       Impact factor: 5.820

Review 3.  Potential Neuroimmune Interaction in Chronic Pain: A Review on Immune Cells in Peripheral and Central Sensitization.

Authors:  Jia-Xuan Yang; Hong-Fei Wang; Ji-Zhun Chen; Han-Yu Li; Ji-Chen Hu; An-An Yu; Jun-Jun Wen; Si-Jia Chen; Wei-Dong Lai; Song Wang; Yan Jin; Jie Yu
Journal:  Front Pain Res (Lausanne)       Date:  2022-07-04

4.  Exercise Reverses Nociceptive Sensitization, Upregulated Neuropeptide Signaling, Inflammatory Changes, Anxiety, and Memory Impairment in a Mouse Tibia Fracture Model.

Authors:  Xiaoyou Shi; Tian-Zhi Guo; Wenwu Li; Peyman Sahbaie; Kenner C Rice; Agnieszka Sulima; J David Clark; Wade S Kingery
Journal:  Anesthesiology       Date:  2018-09       Impact factor: 7.892

5.  IL-6 signaling mediates the germinal center response, IgM production and nociceptive sensitization in male mice after tibia fracture.

Authors:  Wen-Wu Li; Yang Yang; Tian-Zhi Guo; Peyman Sahbaie; Xiao-You Shi; Qin Guang; Wade S Kingery; Leonore A Herzenberg; J David Clark
Journal:  Brain Behav Immun       Date:  2021-02-23       Impact factor: 7.217

6.  Autonomic Regulation of Nociceptive and Immunologic Changes in a Mouse Model of Complex Regional Pain Syndrome.

Authors:  Peyman Sahbaie; Wen-Wu Li; Tian-Zhi Guo; Xiao-You Shi; Wade S Kingery; J David Clark
Journal:  J Pain       Date:  2021-10-23       Impact factor: 5.820

7.  Complex regional pain syndrome patient immunoglobulin M has pronociceptive effects in the skin and spinal cord of tibia fracture mice.

Authors:  Tian-Zhi Guo; Tzuping Wei; Maral Tajerian; J David Clark; Frank Birklein; Andreas Goebel; Wen-Wu Li; Peyman Sahbaie; Fabiola L Escolano; Myriam Herrnberger; Heidrum H Kramer; Wade S Kingery
Journal:  Pain       Date:  2020-04       Impact factor: 7.926

8.  Sex differences in the temporal development of pronociceptive immune responses in the tibia fracture mouse model.

Authors:  Tian-Zhi Guo; Xiaoyou Shi; Wen-Wu Li; Tzuping Wei; J David Clark; Wade S Kingery
Journal:  Pain       Date:  2019-09       Impact factor: 7.926

9.  Dimethyl Fumarate Reduces Oxidative Stress and Pronociceptive Immune Responses in a Murine Model of Complex Regional Pain Syndrome.

Authors:  Tian-Zhi Guo; Xiaoyou Shi; Wenwu Li; Tzuping Wei; Wade S Kingery; J David Clark
Journal:  Anesth Analg       Date:  2021-05-01       Impact factor: 6.627

10.  C5a complement and cytokine signaling mediate the pronociceptive effects of complex regional pain syndrome patient IgM in fracture mice.

Authors:  Xiaoyou Shi; Tian-Zhi Guo; Wen-Wu Li; Frank Birklein; Fabiola L Escolano; Myriam Herrnberger; J David Clark; Wade S Kingery
Journal:  Pain       Date:  2021-05-01       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.